<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: August 2020]]></title>
	<link>https://bioinformaticsonline.com/news/archive/shruti/1596258000/1598936400?</link>
	<atom:link href="https://bioinformaticsonline.com/news/archive/shruti/1596258000/1598936400?" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/42141/dbt-biotechnology-eligibility-test-bet-2020</guid>
	<pubDate>Fri, 21 Aug 2020 09:17:24 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/42141/dbt-biotechnology-eligibility-test-bet-2020</link>
	<title><![CDATA[DBT BIOTECHNOLOGY ELIGIBILITY TEST (BET) 2020]]></title>
	<description><![CDATA[<p><span>Ministry of Science &amp;Technology, Govt. of India</span></p><p><span>DBT-Junior Research Fellowship (DBT-JRF) in Biotechnology (2020)</span></p><p><span><span>BIOTECHNOLOGY ELIGIBILITY TEST (BET) 2020</span></span></p><p>Applications are invited from bonafide Indian citizens, residing in India for award of &ldquo;DBT-Junior Research Fellowship&rdquo; (DBT-JRF) for pursuing research in frontier areas of Biotechnology and Life Sciences. The candidates will be selected through &ldquo;Biotechnology Eligibility Test (BET)&rdquo;. Based on the performance in BET, two categories of merit list will be prepared (Category-I and Category-II). Government of India norms for reservation will be followed for selection. Candidates selected under category-I will be eligible to avail fellowship under the programme. These will be tenable at any University/Institute in India where the selected candidate registers for PhD Programme. Candidates selected under Category-II will be eligible to be appointed in any DBT sponsored project and avail fellowship from the project equivalent to NET/GATE, subject to selection through institutional selection process. There will be no binding on Principal Investigators of DBT sponsored projects to select JRF for their project from category-II list. Selection in category-II will not entitle student for any fellowship from DBT-JRF programme.</p><p><span>ELIGIBILITY</span></p><p><span>Qualification</span>: M.Sc./ M.Tech./ M.V.Sc. or equivalent degree/ Integrated BS-MS/ B.E./ B.Tech. in any discipline of&nbsp;<a href="https://www.biotecnika.org/category/jobs/biotech-jobs/">Biotechnology</a>, M.Sc./ M.Tech. Bioinformatics/ Computational Biology, students admitted under DBT supported Postgraduate Teaching Programs. M.Sc. Life Science/ Bioscience/ Zoology/ Botany/ Microbiology/ Biochemistry/ Biophysics and Masters in Allied areas of Biology/Life Sciences. Candidates appearing in the final year examination are also eligible to apply.</p><p><span>Marks</span>: Minimum 60% marks for General, EWS &amp; OBC category and 55% for SC/ ST/ Differently abled in aggregate (or equivalent grade).</p><p><span>Age Limit</span>: Upto 28 years as on the last date of application for General &amp; EWS category. Age relaxation of up to 5 years (33 years) for SC/ ST/ Differently Abled/ women candidates and upto 3 years (31 years) for OBC (Non-Creamy Layer) candidates.</p><p>For detailed procedure for filling the application form, payment of application fee and uploading of required documents/ certificates in the prescribed format, please visit:&nbsp;<span><a href="http://rcb.res.in/BET2020" target="_blank">http://rcb.res.in/BET2020</a></span>. A non-refundable and non-transferable application fee of Rs. 1000/-is payable online by General/ OBC/ EWS candidates and Rs 250/- by SC/ ST/ Differently abled candidates.</p><p><span>IMPORTANT DATES</span></p><table width="691">
<tbody>
<tr>
<td>Online Registration Start</td>
<td><span>April 20, 2020</span></td>
</tr>
<tr>
<td>Online Registration Close</td>
<td><span>May 18, 2020</span></td>
</tr>
<tr>
<td>BET 2020</td>
<td><span>June 30, 2020 (Tuesday)* Tentative</span></td>
</tr>
<tr>
<td>Display of question paper and answer key on website</td>
<td><span>June 30, 2020</span></td>
</tr>
<tr>
<td>Last date of accepting representation of any discrepancy in Question paper &amp; Answer key</td>
<td><span>July 03, 2020</span></td>
</tr>
<tr>
<td>Declaration of BET 2020 Result</td>
<td><span>July 20, 2020</span></td>
</tr>
</tbody>
</table>]]></description>
	<dc:creator>Shruti Paniwala</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/42023/encode3-a-collection-of-research-articles-and-related-content-describing-the-encyclopedia-of-dna-elements-its-datasets-and-tools</guid>
	<pubDate>Sat, 08 Aug 2020 08:25:21 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/42023/encode3-a-collection-of-research-articles-and-related-content-describing-the-encyclopedia-of-dna-elements-its-datasets-and-tools</link>
	<title><![CDATA[ENCODE3: A collection of research articles and related content describing the Encyclopedia of DNA Elements, its datasets and tools.]]></title>
	<description><![CDATA[<p>How cells, tissues and organisms interpret the information encoded in the genome has vital implications for our understanding of development, health and disease. Launched in 2003, the ENCyclopedia Of DNA Elements (ENCODE) project has the aim of mapping the functional elements in the human genome (later expanded to include model organisms).</p><p>During the first phase of ENCODE, published in 2007, microarray-based technologies were used to detect regions associated with transcription factors, certain histone modifications and open chromatin within a pre-specified 1% of the human genome.</p><p>ENCODE&rsquo;s second phase saw a switch to sequencing-based technologies, the addition of new assay types and the analysis of functional elements genome-wide, described in a collection of research articles in 2012.</p><p><span>The&nbsp;</span><a href="https://www.nature.com/articles/s41586-020-2493-4">Encyclopedia paper of ENCODE 3</a><span>, published in&nbsp;</span><em>Nature</em><span>, gives an overview of the various assays that were performed in human and mouse cell lines and tissues and describes a Registry of human and mouse candidate&nbsp;</span><em>cis</em><span>-regulatory elements (cCREs).</span></p><p>More at&nbsp;<a href="https://www.nature.com/immersive/d42859-020-00027-2/index.html">https://www.nature.com/immersive/d42859-020-00027-2/index.html</a></p>]]></description>
	<dc:creator>Shruti Paniwala</dc:creator>
</item>

</channel>
</rss>